Safety

News

Closeup of X-ray photography of human brain

Eisai questions link between lecanemab and patient death

With the FDA due to deliver a decision of Eisai and Biogen's new Alzheimer's disease candidate lecanemab tomorrow, the safety of the drug has been thrust into the spotlight by a case report

News

FDA slaps partial hold on Biogen, InnoCare MS drug

Biogen's efforts to replenish its multiple sclerosis pipeline have suffered a setback, after the FDA placed a clinical hold on a drug candidate it licensed from China's InnoCare last year f

Patients

What does the future of European healthcare look like?

After the “stress test” of COVID, how can the sector create resilient, sustainable healthcare systems for the long term?

News

US court throws out lawsuits alleging Zantac caused cancer

Pharma companies involved in the sale of heartburn therapy Zantac have won a key battle in litigation brought by patients who claim the drug caused them to develop cancer.

News

Many women unaware of epilepsy drug safety warning - survey

Nearly seven out of ten women surveyed about an epilepsy drug have not received new safety warnings, according to a new survey.

News

First Zantac cancer case dropped before trial, without settl...

The first lawsuit claiming that gastrointestinal drug Zantac causes cancer has been voluntarily dismissed a week before it was due to come to trial, in an early victory for the pharma compa